• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sacral Nerve-Sparing Piecemeal Spondylectomy for Giant Cell Tumor of Bone in the Sacrum: Surgical Strategy and Accurate Tumor Location Identification.

作者信息

Otsuki Bungo, Sakamoto Akio, Fujibayashi Shunsuke, Shimizu Takayoshi, Murata Koichi, Noguchi Takashi, Matsuda Shuichi

机构信息

Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

出版信息

Spine Surg Relat Res. 2023 Sep 4;8(1):110-113. doi: 10.22603/ssrr.2023-0145. eCollection 2024 Jan 27.

DOI:10.22603/ssrr.2023-0145
PMID:38343402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10853623/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/10853623/619dfcf2ba56/2432-261X-8-0110-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/10853623/871a017f6321/2432-261X-8-0110-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/10853623/0eedb588056f/2432-261X-8-0110-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/10853623/e8cc7359d0aa/2432-261X-8-0110-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/10853623/619dfcf2ba56/2432-261X-8-0110-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/10853623/871a017f6321/2432-261X-8-0110-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/10853623/0eedb588056f/2432-261X-8-0110-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/10853623/e8cc7359d0aa/2432-261X-8-0110-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/10853623/619dfcf2ba56/2432-261X-8-0110-g004.jpg

相似文献

1
Sacral Nerve-Sparing Piecemeal Spondylectomy for Giant Cell Tumor of Bone in the Sacrum: Surgical Strategy and Accurate Tumor Location Identification.保留骶神经的分块椎体切除术治疗骶骨骨巨细胞瘤：手术策略及肿瘤准确位置的识别
Spine Surg Relat Res. 2023 Sep 4;8(1):110-113. doi: 10.22603/ssrr.2023-0145. eCollection 2024 Jan 27.
2
Comparison of the prognostic factors of total en bloc spondylectomy and total piecemeal spondylectomy in patients with Enneking stage III giant cell tumor in the thoracic and lumbar spine.胸椎和腰椎Enneking III期骨巨细胞瘤患者全椎体整块切除术与全椎体分块切除术预后因素的比较。
Eur Spine J. 2023 Jan;32(1):254-260. doi: 10.1007/s00586-022-07455-w. Epub 2022 Nov 16.
3
Total en bloc spondylectomy. A new surgical technique for primary malignant vertebral tumors.整块全脊椎切除术。一种治疗原发性恶性脊椎肿瘤的新手术技术。
Spine (Phila Pa 1976). 1997 Feb 1;22(3):324-33. doi: 10.1097/00007632-199702010-00018.
4
Total spondylectomy for Enneking stage III giant cell tumor of the mobile spine.全脊椎切除术治疗活动脊柱 Enneking 分期 III 期骨巨细胞瘤。
Eur Spine J. 2018 Dec;27(12):3084-3091. doi: 10.1007/s00586-018-5761-3. Epub 2018 Sep 12.
5
Intralesional nerve-sparing surgery versus non-surgical treatment for giant cell tumor of the sacrum.骶骨巨细胞瘤的瘤内神经保护手术与非手术治疗比较。
BMC Musculoskelet Disord. 2021 Dec 6;22(1):1023. doi: 10.1186/s12891-021-04907-0.
6
[Comparison of clinical effects of total spondylectomy with different procedures in treating lumbar metastatic tumor].不同术式全脊椎切除术治疗腰椎转移性肿瘤的临床疗效比较
Zhongguo Gu Shang. 2014 Sep;27(9):745-51.
7
Successful total en bloc spondylectomy of the L3 vertebra with a paravertebral giant cell tumor following preoperative treatment with denosumab: a case report.术前使用地诺单抗治疗后成功进行L3椎体全椎整块切除术及椎旁巨细胞瘤切除：一例报告
J Med Case Rep. 2019 Apr 26;13(1):116. doi: 10.1186/s13256-019-2029-4.
8
One-Step Reconstruction with a Novel Suspended, Modular, and 3D-Printed Total Sacral Implant Resection of Sacral Giant Cell Tumor with Preservation of Bilateral S Nerve Roots via a Posterior-Only Approach.一种新型悬空式、模块化和 3D 打印全骶骨植入物在后入路仅保留双侧 S 神经根的情况下切除骶骨巨细胞瘤的一步重建法。
Orthop Surg. 2020 Feb;12(1):58-66. doi: 10.1111/os.12582. Epub 2019 Dec 18.
9
Surgical Strategy for Recurrent Giant Cell Tumor in the Thoracolumbar Spine.胸腰椎复发性巨细胞瘤的手术策略。
Orthop Surg. 2024 Jan;16(1):78-85. doi: 10.1111/os.13911. Epub 2023 Nov 28.
10
Clinical features and prognostic factors of pediatric spine giant cell tumors: report of 31 clinical cases in a single center.小儿脊柱巨细胞瘤的临床特征及预后因素：单中心 31 例临床报告。
Spine J. 2019 Jul;19(7):1232-1241. doi: 10.1016/j.spinee.2019.02.011. Epub 2019 Feb 15.

本文引用的文献

1
Multifidus muscle retracted and preserved in resection of malignant bone tumor in the sacral ala.在骶骨翼恶性骨肿瘤切除术中，多裂肌被牵开并保留。
J Surg Case Rep. 2021 Oct 12;2021(10):rjab439. doi: 10.1093/jscr/rjab439. eCollection 2021 Oct.
2
Efficacy of Intrawound Treatments to Prevent Surgical Site Infection after Spine Surgery: A Systematic Review and Network Meta-analysis.脊柱手术后预防手术部位感染的切口内治疗效果：系统评价和网络荟萃分析。
Pain Physician. 2021 Sep;24(6):E709-E720.
3
Risk factors for the local recurrence of giant cell tumours of the sacrum treated with nerve-sparing surgery.
骶骨巨细胞瘤行保留神经手术治疗后局部复发的危险因素。
Bone Joint J. 2020 Oct;102-B(10):1392-1398. doi: 10.1302/0301-620X.102B10.BJJ-2020-0276.R1.
4
Retrospective cohort study of 68 sacral giant cell tumours treated with nerve-sparing surgery and evaluation on therapeutic benefits of denosumab therapy.回顾性队列研究 68 例骶骨巨细胞瘤采用保留神经手术治疗，并评估地舒单抗治疗的疗效获益。
Bone Joint J. 2020 Feb;102-B(2):177-185. doi: 10.1302/0301-620X.102B2.BJJ-2019-0813.R1.
5
Total spondylectomy for Enneking stage III giant cell tumor of the mobile spine.全脊椎切除术治疗活动脊柱 Enneking 分期 III 期骨巨细胞瘤。
Eur Spine J. 2018 Dec;27(12):3084-3091. doi: 10.1007/s00586-018-5761-3. Epub 2018 Sep 12.
6
Decreased rate of surgical site infection after spinal surgery with instrumentation using bundled approach including surveillance and intrawound vancomycin application.采用包括监测和伤口内应用万古霉素在内的集束化方法进行脊柱内固定手术后手术部位感染率降低。
Medicine (Baltimore). 2018 Aug;97(34):e12010. doi: 10.1097/MD.0000000000012010.
7
Recurrence Factors in Giant Cell Tumors of the Spine.脊柱骨巨细胞瘤的复发因素
Chin Med J (Engl). 2017 Jul 5;130(13):1557-1563. doi: 10.4103/0366-6999.208239.
8
Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone.在一项开放标签的II期试验中，地诺单抗用于骨巨细胞瘤患者的手术降期。
Ann Surg Oncol. 2015 Sep;22(9):2860-8. doi: 10.1245/s10434-015-4634-9. Epub 2015 Jun 2.
9
Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study.地舒单抗治疗骨巨细胞瘤患者的开放性、2 期研究。
Lancet Oncol. 2010 Mar;11(3):275-80. doi: 10.1016/S1470-2045(10)70010-3. Epub 2010 Feb 10.
10
Outcome of conservative surgery for giant cell tumor of the sacrum.骶骨巨细胞瘤保守手术的结果。
Spine (Phila Pa 1976). 2009 May 1;34(10):1025-31. doi: 10.1097/BRS.0b013e31819d4127.